Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Risk Assessment
Sort By
Newest First
1 / 1
1 / 1
New CDMO Facility
Leveraging a State-of-the-Art CDMO Facility to Advance Healthcare
Grifols
PAO-02-23-PATV-04
Feb 23, 2023
CAPA Management
CAPA Management is Worth Doing, and Worth Doing Well
Helen Lowe
PAO-04-022-CL-11
May 04, 2022
Regulatory
FDA Makes Low-Risk Determination for Marketing of Products from Genome-Edited Beef Cattle After Safety Review
U.S. Food & Drug Administration
PR-M03-22-03
Mar 07, 2022
Nitrosamine
Supporting Drug Manufacturers with Emprove® Nitrosamine Declarations
Ulrich Reichert, M.D.R.A.
MilliporeSigma
PAO-02021-CL-05
Feb 10, 2021
Roundtable
Q: Although there is no such thing as a truly “crisis-proof” organization, how are you working to mitigate risks for future crises like the COVID-19 pandemic?
Pharma's Almanac
PAP-Q4-20-NI-007
Dec 09, 2020
Equipment
Fit Biopharmaceutical Facilities: A Predictive Maintenance Approach
CRB USA
PAP-Q2-17-CL-010
Jun 05, 2017
Keeping it Clean
Nice Insight
PTV-M11-16-AP-005
Apr 06, 2017
